Scholarlink

<p>Myocardial infarction, a leading cause of mortality worldwide, creates an urgent need for effective strategies to regenerate damaged heart tissue. In this study, a novel nanofibrous hydrogel scaffold based on polypropylene fumarate (PPF)-methoxy polyethylene glycol (mPEG) copolymer, enriched with sitagliptin-loaded polypyrrole (PPy) nanoparticles (PPy-S NPs) was developed, to enhance myocardial tissue regeneration. Sitagliptin was incorporated into the formulation as a pro-angiogenic agent known to stimulate the expression of angiogenesis-related genes. The PPF-mPEG copolymer (CP) was synthesized via a multi-step transesterification process, creating a hydrophilic scaffold that promotes cellular adhesion and proliferation. Characterization of the CP/PPy-S scaffold revealed a well-distributed nanofiber network with a mean fiber diameter of 117.43&#xa0;nm. Swelling ratio analysis showed high water uptake, with CP/PPy-S nanofibers reaching peak swelling of 1603.23% on day 14. Degradation studies demonstrated progressive weight loss over 28 days, with CP/PPy-S nanofibers displaying a slightly higher degradation rate compared to other groups. Drug release profiles indicated sustained sitagliptin release from the nanofibers, achieving a cumulative release of 92.86% over 14 days. Cytocompatibility testing using H9C2 cardiomyocytes showed significant enhancement in cell viability on CP/PPy-S nanofibers compared to other samples. These findings demonstrate that the nanofibrous scaffold not only provides mechanical support but also offers controlled drug release and electrical conductivity, both of which are crucial for myocardial regeneration. The integration of sitagliptin and PPy nanoparticles promotes cell viability, angiogenesis, and tissue-specific properties, making this scaffold a promising candidate for cardiac tissue engineering applications.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Electroconductive Polypropylene Fumarate-Methoxy Polyethylene Glycol Nanofibers Containing Sitagliptin-Loaded Polypyrrole Nanoparticles for Cardiac Tissue Engineering

  • 期刊论文

  • 发表日期：

    2026年1月16日

查看全文
  • Mohamadreza Tavakoli,
  • Jaleh Varshosaz,
  • Marjan Mirhaj,
  • Mahboubeh Rostami,
  • Mina Shahriari-Khalaji,
  • Mastafa H. Al-Musawi,
  • Ahmed A. Mohammed,
  • Basma Talib Al-Sudani,
  • Adel Marzban,
  • Mamoona Sattar,
  • Vala Vahedian Boroujeni,
  • Fariborz Sharifianjazi,
  • Tengiz Tkebuchava,
  • Ketevan Tavamaishvili,
  • Salar Nasr Esfahani,
  • Amirali hariri,
  • Afsaneh Yegdaneh

摘要

Myocardial infarction, a leading cause of mortality worldwide, creates an urgent need for effective strategies to regenerate damaged heart tissue. In this study, a novel nanofibrous hydrogel scaffold based on polypropylene fumarate (PPF)-methoxy polyethylene glycol (mPEG) copolymer, enriched with sitagliptin-loaded polypyrrole (PPy) nanoparticles (PPy-S NPs) was developed, to enhance myocardial tissue regeneration. Sitagliptin was incorporated into the formulation as a pro-angiogenic agent known to stimulate the expression of angiogenesis-related genes. The PPF-mPEG copolymer (CP) was synthesized via a multi-step transesterification process, creating a hydrophilic scaffold that promotes cellular adhesion and proliferation. Characterization of the CP/PPy-S scaffold revealed a well-distributed nanofiber network with a mean fiber diameter of 117.43 nm. Swelling ratio analysis showed high water uptake, with CP/PPy-S nanofibers reaching peak swelling of 1603.23% on day 14. Degradation studies demonstrated progressive weight loss over 28 days, with CP/PPy-S nanofibers displaying a slightly higher degradation rate compared to other groups. Drug release profiles indicated sustained sitagliptin release from the nanofibers, achieving a cumulative release of 92.86% over 14 days. Cytocompatibility testing using H9C2 cardiomyocytes showed significant enhancement in cell viability on CP/PPy-S nanofibers compared to other samples. These findings demonstrate that the nanofibrous scaffold not only provides mechanical support but also offers controlled drug release and electrical conductivity, both of which are crucial for myocardial regeneration. The integration of sitagliptin and PPy nanoparticles promotes cell viability, angiogenesis, and tissue-specific properties, making this scaffold a promising candidate for cardiac tissue engineering applications.

Graphical Abstract